Position in AZN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,202,570
New position
Shares Held
6,342
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#627
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cooper Financial Group holds $19,451,562 across 11 Drug Manufacturers - General names. AZN ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,274 | $6,325,794 | |
| 2 | AMGN |
Amgen Inc
|
8,265 | $2,992,921 | |
| 3 | ABBV |
AbbVie Inc.
|
11,460 | $2,883,794 | |
| 4 | JNJ |
Johnson & Johnson
|
10,851 | $2,755,828 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
6,342 | $1,202,570 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,089 | $1,039,436 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,387 | $713,738 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,403 | $556,275 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,202,570 | 6,342 | Shares | Sole | 2026-07-08 | |
| No filing history on record for this holder in this stock. | ||||||